Impact of Albumin on Renal function in critically ill patients with Septic Shock and a high risk of Acute Kidney Injury. A Randomized Controlled Trial

• Protocol code: ALBUMIR-AKI
• EudraCT code: No aplica
• Research group: Shock, Organ Dysfunction and Resuscitation
• Service: RTA ICU
• Principal investigator:  Ferrer Roca, Ricard
• Pathology: Tumors
• Phase: Fase II

Estudio de fase III, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia, la seguridad y la tolerabilidad del remibrutinib en pacientes con miastenia grave generalizada, seguido de una fase de extensión abierta.

• Protocol code: CLOU064O12301
• EudraCT code: No aplica
• Research group: Peripheral Nervous System
• Service: Neurology
• Principal investigator:  Juntas Morales, Raul
• Pathology: Tumors
• Phase: Fase III

A phase IIa double-blind, randomized, parallel-arm, placebo-controlled trial to investigate the effects of three dose levels of CIT-013 on disease activity in patients with moderately active rheumatoid arthritis.

• Protocol code: CITRYLL002-Citydream
• EudraCT code: _
• Research group: Rheumatology
• Service: Rheumatology
• Principal investigator:  Lopez Lasanta, Maria America
• Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
• Phase: Fase II